BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ceaglio N, Gugliotta A, Tardivo MB, Cravero D, Etcheverrigaray M, Kratje R, Oggero M. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit. J Biotechnol 2016;221:13-24. [PMID: 26806490 DOI: 10.1016/j.jbiotec.2016.01.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Wang C, Ma F, Yao L, Gao H, Zhu L, Zheng L. Development and biological activity of long-acting recombinant human interferon-α2b. BMC Biotechnol 2020;20:16. [PMID: 32169063 DOI: 10.1186/s12896-020-00605-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gugliotta A, Ceaglio N, Etcheverrigaray M, Kratje R, Oggero M. Strategies to Develop Therapeutic N- and O-Hyperglycosylated Proteins. In: Picanço-castro V, Swiech K, editors. Recombinant Glycoprotein Production. New York: Springer; 2018. pp. 163-81. [DOI: 10.1007/978-1-4939-7312-5_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Dias PVS, Arthuso FS, Oliveira JE, Suzuki MF, Sousa JM, Ribela MTCP, Bartolini P, Soares CRJ. Determination of recombinant Interferon-α2 in E. coli periplasmic extracts by reversed-phase high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1072:193-8. [PMID: 29179059 DOI: 10.1016/j.jchromb.2017.11.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Gugliotta A, Ceaglio N, Kratje R, Oggero M. Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variant. J Biotechnol 2019;303:46-52. [PMID: 31336133 DOI: 10.1016/j.jbiotec.2019.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wangler NJ, Jayaraman S, Zhu R, Mechref Y, Abbruscato TJ, Bickel U, Karamyan VT. Preparation and preliminary characterization of recombinant neurolysin for in vivo studies. J Biotechnol 2016;234:105-15. [PMID: 27496565 DOI: 10.1016/j.jbiotec.2016.07.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Bello C, Rovero P, Papini AM. Just a spoonful of sugar: Short glycans affect protein properties and functions. J Pept Sci 2019;25:e3167. [PMID: 30924227 DOI: 10.1002/psc.3167] [Reference Citation Analysis]
7 Serna N, Pallarès V, Unzueta U, Garcia-Leon A, Voltà-Durán E, Sánchez-Chardi A, Parladé E, Rueda A, Casanova I, Falgàs A, Alba-Castellón L, Sierra J, Villaverde A, Vázquez E, Mangues R. Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery. J Control Release 2022;343:277-87. [PMID: 35051493 DOI: 10.1016/j.jconrel.2022.01.017] [Reference Citation Analysis]
8 Gugliotta A, Ceaglio N, Raud B, Forno G, Mauro L, Kratje R, Oggero M. Glycosylation and antiproliferative activity of hyperglycosylated IFN-α2 potentiate HEK293 cells as biofactories. Eur J Pharm Biopharm 2017;112:119-31. [PMID: 27867113 DOI: 10.1016/j.ejpb.2016.11.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
9 Sales MLM, Kratje R, Oggero M, Ceaglio N. Bifunctional GM-CSF-derived peptides as tools for O-glycoengineering and protein tagging. J Biotechnol 2021;327:18-27. [PMID: 33387593 DOI: 10.1016/j.jbiotec.2020.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Dubeykovskaya ZA, Duddempudi PK, Deng H, Valenti G, Cuti KL, Nagar K, Tailor Y, Guha C, Kitajewski J, Wang TC. Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer. Cancer Gene Ther 2019;26:48-57. [PMID: 30042499 DOI: 10.1038/s41417-018-0036-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]